David Pernock

President and Chief Commercial Officer


Mr. Pernock is Eagle’s President and Chief Commercial Officer.  He brings vast experience in the pharmaceutical and biotechnology space.  Mr. Pernock served as a member of Eagle’s Board from April 2015 through December 2016.

Prior to Eagle, Mr. Pernock served as Chairman of the Board of Directors and Chief Executive Officer (2010 – 2017) of Fibrocell Science, Inc., a publicly-traded autologous cell and gene therapy company.

Mr. Pernock held various positions at GlaxoSmithKline, most notably serving as Senior Vice President of Pharmaceuticals, Vaccines (Biologics), Oncology, Acute Care, and HIV Divisions.  He also served as President of Reliant Pharmaceuticals.  Furthermore, Mr. Pernock served as a director of Martek Biosciences Corporation.

Mr. Pernock holds a B.S. in Business Administration from Arizona State University.